Population screening
Lung cancer is the leading cause of death of cancer in Slovakia and EU. According to data from the National Oncology Register, lung cancer was the third most commonly diagnosed malignant disease in men and fourth most commonly diagnosed malignant disease in women in Slovakia in 2014 (Incidence of malignant tumors in the SR 2014). That year, gross incidence of lung cancer in men was 67.7 per 100,000 men and it reached 24.1 cases per 100,000 women.
A model projection for 2022 in Slovakia is 3,154 new cases of lung cancer, of which 2,191 cases in men and 963 cases in women. For men, lung cancer had the highest mortality of all malignant tumors in Slovakia in 2021, for women, it was the second highest after breast cancer. 1,957 people died of lung cancer in Slovakia that year, of which 1,359 men and 598 women. Standardized male mortality for global population was 27.12 per 100,000 people and standardized female mortality for global population was 8.93 per 100,000 people. Lung cancer mortality prediction for 2022 is 1,405 men and 641 women. Experience and data from countries with implemented early-detection lung cancer screening in connection with quitting smoking programs show that implementing these processes in Slovakia is meaningful.
